Issues relating to the the Promoting and Respecting Economically Vital American Innovation Leadership Act (PREVAIL) (H.R. 3152) and Patent Eligibility Restoration Act (PERA) (S. 1546) patent legislation
2026 · 3rd Quarter (July 1 - Sep 30)
MEDICAL DEVICE MANUFACTURERS ASSOCIATION
Filed by MEDICAL DEVICE MANUFACTURERS ASSOCIATION.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 19, 2026
- Income
- Not reported
- Expenses
- $340,000.00
- Registrant
- MEDICAL DEVICE MANUFACTURERS ASSOCIATION
- Filing UUID
- be5473e1-a5d3-4760-b842-13fd118a5939
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
Issues related to MDUFA implementation; FDA staffing Issues relating to the medical product supply chain Issues related to medical device sterilization and the use of ethylene oxide to sterilize medical devices Issues related to HR 3723 - the Medical Device Electronic Labeling Act Issues related to PFAS and EtO Chemical regulation Issues related to cyber security Issues related to consumer and health data privacy Issues related to regulation of artificial intelligence in healthcare Issues related to competitive bidding Issues related to the National Defense Authorization Act (NDAA)
Literal federal measure citations: HR 3723
Issues related to Medicare coverage reform Issues related to the coverage for FDA Breakthrough products and the H.R. 5343 and S.1717 Ensuring Patient Access to Critical Breakthrough Products Act TCET Issues related to the Regulatory Alignment for Predictable and Immediate Device (RAPID) coverage pathway Issues related to the New Technology Add on Payment (NTAP) Issues related to coverage of telehealth services Issues related to physician fee schedule Issues related to CMS expansion of prior authorization requirements for medical procedures Issues related to reimbursement of artificial intelligence in healthcare Issues related to competitive bidding
Issues related to global trade and tariffs Issues related to United States-Mexico-Canada Agreement (USMCA)
Issues related to appropriations and user fee funding for the Food and Drug Administration
Issues related to the reauthorization of the Small Business Innovation Research (SBIR) Program
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.